Clinical trial
Levetiracetam in Post-Traumatic Stress Disorder
NCT00413296 · Duke University, Other · Completed
Key facts
| NCT number | NCT00413296 |
|---|---|
| Title | Levetiracetam in Post-Traumatic Stress Disorder |
| Official title | A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder |
| Acronym | PTSD |
| Lead sponsor | Duke University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | levetiracetam, Placebo, Levetriracetam |
| Enrollment | 16 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Dec 19, 2006 |
| Last update posted | Jul 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: